The Case | Post-tranplant allograft dysfunction

Aubert, Olivier; Galmiche, Louise; Rozenberg, Flore; Duquesne, Alyette; Scemla, Anne; Rabant, Marion; Leruez, Marianne; Laude, Hélène; Legendre, Christophe; Sberro-Soussan, Rebecca
April 2013
Kidney International;Apr2013, Vol. 83 Issue 4, p765
Academic Journal
The article presents a case study of a 43-year-old man who was treated for human immunodeficiency virus type 2 (HIV2) and has an end-stage renal disease. The patient has received various treatment including zidovudine, didanosine, and intravenous immunoglobulin. It discusses the significance of immunohistochemistry for SV40 and polymerase chain reaction (PCR) and John Cunningham virus (JCV).


Related Articles

  • Use of John Cunningham virus polymerase chain reaction in the diagnosis of progressive multifocal leucoencephalopathy - A rare presenting manifestation in an HIV-positive patient. Datta, S.; Wattal, C.; Sethi, P. K.; Buxi, T. B. S.; Jain, D. // Indian Journal of Medical Microbiology;Apr2012, Vol. 30 Issue 2, p239 

    John Cunningham virus infection is an important cause of progressive multifocal leucoencephalopathy (PML) in the context of advanced human immunodefi ciency virus infection. Limited data are available regarding the true incidence of PML as a presenting manifestation of HIV. We report one such...

  • JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level. Lanzillo, Roberta; Liuzzi, Raffaele; Vallefuoco, Luca; Moccia, Marcello; Amato, Luca; Vacca, Giovanni; Vacchiano, Veria; Portella, Giuseppe; Brescia Morra, Vincenzo // Therapeutics & Clinical Risk Management;2014, Vol. 10, p807 

    Natalizumab-treated patients have a higher risk of developing progressive multifocal leukoencephalopathy. Exposure to John Cunningham virus (JCV) is a prerequisite for PML (progressive multifocal leukoencephalopathy). To assess JCV exposure in multiple sclerosis patients, we performed a...

  • Use of darunavir and enfuvirtide in a pregnant woman. Sued, O.; Lattner, J.; Gun, A.; Patterson, P.; Abusamra, L.; Cesar, C.; Fink, V.; Krolewiecki, A.; Cahn, P. // International Journal of STD & AIDS;Dec2008, Vol. 19 Issue 12, p866 

    A 41-year-old pregnant woman with multiple virological failures started darunavir, enfuvirtide, zidovudine and lamivudine at week 28 of pregnancy. During week 38, the patient had a viral load < 400 copies/mL and a CD4 count of 180 cells/mm³ (13%). The child was found to be in good health,...

  • Aberrant Expression of Immunoglobulin Heavy Chain Genes in Epstein-Barr Virus-Negative, Human Immunodeficiency Virus-Related Lymphoid Interstitial Pneumonia. Kurosu, Katsushi; Yumoto, Norio; Rom, William N.; Jaishree, Jagirdar; Nakata, Koh; Kuriyama, Takayuki; Mikata, Atsuo; Weiden, Michael D. // Laboratory Investigation (00236837);Dec2000, Vol. 80 Issue 12, p1891 

    The two-step polymerase chain reaction (PCR) and sequencing analysis was used to analyze the immunoglobulin heavy chain variable (Ig VH) genes of open-chest biopsy or autopsy samples from five patients with Epstein-Barr virus-negative human immunodeficiency virus (HIV)-related lymphoid...

  • The size and composition of circulating immune complexes during HIV infection. Korolevskaya, L.; Shmagel, K.; Shmagel, N.; Chereshnev, V. // Doklady Biochemistry & Biophysics;Jul2014, Vol. 457 Issue 1, p134 

    The article presents a study which evaluates the qualitative composition and quantity of circulating immune complexes (CICs) in HIV-infected patients with different viral load (VL) levels. It mentions that blood sampling and real-time polymerase chain reaction (PCR) were performed. It shows that...

  • Epidemiological aspects of HCV infection in HIV-infected individuals in Piauí State, Northeast Brazil. Oliveira-Filho, Aldemir; Oliveira, Evaldo; Castro, Jairo; Silva, Letiano; Vallinoto, Antonio; Lemos, José // Archives of Virology;Dec2012, Vol. 157 Issue 12, p2411 

    In this study, the prevalence, genotypic frequency, and risk factors for HCV infection in 768 patients infected with HIV were determined. Fifty-two (6.77 %) HIV-positive individuals had anti-HCV antibodies and 26 (3.39 %) had HCV-RNA. Genotyping results indicated that all RT-PCR samples from...

  • Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. Worm, Signe Westring; Sabin, Caroline; Weber, Rainer; Reiss, Peter; El-Sadr, Wafaa; Dabis, Francois; De Wit, Stephane; Law, Matthew; D'Arminio Monforte, Antonella; Friis-Møller, Nina; Kirk, Ole; Fontas, Eric; Weller, Ian; Phillips, Andrew; Lundgren, Jens // Journal of Infectious Diseases;2/1/2010, Vol. 201 Issue 3, p318 

    Background. The risk of myocardial infarction (MI) in patients with human immunodeficiency virus (HIV) infection has been assessed in 13 anti-HIV drugs in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Methods. Poisson regression models were adjusted for cardiovascular...

  • Frequency of PCR testing in HIV patients. M.O.R. // Cortlandt Forum;02/25/98, Vol. 11 Issue 2, p82 

    Responds to query about the required frequency of polymerase chain reaction (PCR) testing for HIV patients. Usefulness of the quantitative measurement of RNA from HIV patients in establishing prognosis; PCR testing every four to six months as well as before beginning any therapy.

  • Changes in hepatitis A virus seroepidemiology in HIV-infected Brazilian patients. Aloisse, R.; de Almeida, A. J.; Sion, F. S.; Morais-de-Sá, C. A.; Gaspar, A. M. C.; de Paula, V. S. // International Journal of STD & AIDS;May2008, Vol. 19 Issue 5, p321 

    Shifting of hepatitis A virus (HAV) epidemiology from a high towards an intermediate endemicity pattern and use of antiretroviral therapy increased the risk of HIV/HAV coinfection in developing countries. The aim of this study was to investigate the presence of HAV markers in a cohort of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics